InnoCan Pharma Corporation (INNPF)

Market Cap	11.06M -72.5%
Revenue (ttm)	25.28M -17.0%
Net Income	-1.51M
EPS	-0.34
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	2.354
Previous Close	n/a
Day's Range	2.354 - 2.450
52-Week Range	2.450 - 14.260
Beta	-0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About InnoCan Pharma

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vag...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2017
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: INNPF

Financial Performance

In 2025, InnoCan Pharma's revenue was $26.61 million, a decrease of -9.60% compared to the previous year's $29.44 million. Losses were -$1.12 million, -38.71% less than in 2024.